title: Transplantation: BENEFIT of belatacept: kidney transplantation moves forward.
authors.affiliation: Department of Microbiology and Immunology, KU Leuven - University of Leuven, Herestraat 49, 3000 Leuven, Belgium.
authors.forename: Maarten
authors.initials: M
authors.lastname: Naesens
authors.affiliation: Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, HCL, 5 Place d'Arsonval, 69003 Lyon, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Thaunat
mesh_terms: D000069594:Abatacept; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection; D006801:Humans; D018796:Immunoconjugates; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation
chemical_list: D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D000069594:Abatacept; D016572:Cyclosporine